{
  "documentMetadata": {
    "title": "Brucella sp., Brucellosis, Febrile Illness",
    "lastUpdated": "2023-10-10",
    "sourceFile": "Brucella sp., Brucellosis, Febrile Illness.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 2,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Brucellosis is a zoonotic febrile illness seen in children and adults",
        "Associated with consumption of unpasteurized milk, exposure to cows, goats, pigs, or sheep, and inadvertent laboratory exposure during handling of Brucella infected tissue or cultures",
        "In rare cases, exposure to Brucella sp in marine mammal (e.g., porpoise) (MMWR 61:461, 2012).",
        "Also known as Malta fever, Mediterranean fever and Undulant fever.",
        "Clinical disease:",
        "  - Protean manifestations: febrile illness, osteoarticular disease (20-30%, especially sacroileitis), rare meningitis or endocarditis",
        "  - Can infect any tissue in the body",
        "Fever occurs in 90%",
        "Malodorous perspiration almost pathognomic but uncommon",
        "Relapse rate, post-treatment, is 10%.",
        "Lab findings: Mild hepatitis; leukopenia and relative lymphocytosis.",
        "General principles governing treatment:",
        "  - Use antibiotics with activity in an acidic intracellular environment: e.g. doxycycline and rifampin",
        "  - Prefer combination therapy to decrease risk of relapse",
        "  - Often need prolonged duration of therapy"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "Slow growing small coccobacilli",
        "Serology, bone marrow culture, real-time PCR or 16s rRNA if available.",
        "Inform lab of possible brucellosis to lower risk of occupational exposure",
        "Serology remains useful in underdeveloped countries",
        "  - All positive rapid serologies require confirmation with Brucella sp. specific agglutination.",
        "  - False negative can occur due to prozone phenomena",
        "NAAT (PCR) and 16S rRNA gene sequencing most sensitive and specific if available and certified",
        "Reference: Clin Micro Rev 2019;33: e00073."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Brucella abortus (cattle)",
        "Brucella suis (pig)",
        "Brucella melitensis (goat, camel (Middle East))",
        "Brucella canis (dog)"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Primary Regimens"
    },
    {
      "type": "list",
      "items": [
        "Non-pregnant Adults and children age > 8 years with non-localizing disease:",
        "  - Doxycycline 100 mg po bid x 6 weeks + Gentamicin 5 mg/kg IV once daily x 7 days",
        "  - Doxycycline 100 mg po bid x 6 weeks + Rifampin 600-900 mg po once daily x 6 weeks",
        "Children age < 8 years with non-localizing disease:",
        "  - (TMP-SMX 5 mg/kg (TMP component) po q12h x 6 weeks) + Rifampin 15-20 mg/kg (max 900 mg/day) po divided in one or two doses",
        "Adults and children age > 8 years with spondylitis/sacroileitis/arthritis.",
        "  - (Doxycycline 100 mg po bid + Rifampin 600-900 mg po q24h-both x 3 months) + once daily Gentamicin IV for first 7 days",
        "  - Ciprofloxacin 750 mg po bid + Rifampin 600-900 mg po once daily: both for a minimum of 3 months",
        "Pregnancy (<36 wks gestation):",
        "  - (TMP-SMX 5 mg/kg of TMP component po bid + Rifampin 600-900 mg po q24h) x 4 weeks",
        "  - If ≥ 36 wks duration, Rifampin monotherapy until delivery",
        "Neurobrucellosis:",
        "  - Doxycycline 100 mg IV/po bid + Rifampin 600-900 mg po once daily + Ceftriaxone 2 gm IV q12h. Continue until CSF is normal.",
        "Endocarditis:",
        "  - Almost always need surgery plus antibiotics. Gentamicin 5 mg/kg IV once daily x 2-4 weeks + combination of Rifampin, Doxycycline and TMP-SMX x 6 weeks to 6 months.",
        "Spondylitis",
        "  - Adult: Doxycycline 100 mg po bid for a minimum of 12 weeks + Rifampin 600-900 mg po once daily for at least 12 weeks + Gentamicin 5 mg/kg IM/IV once daily for the first 7-14 days",
        "  - Child age ≥ 8 yrs: Doxycycline 4.4 mg/kg once daily (max 200mg/day) in 2 divided doses x 12 or more weeks + Rifampin 15-20 mg/kg/day (max 900 mg/day) po once daily x at least 12 weeks + Gentamicin 5 mg/kg IV/IM once daily for first 7-14 days",
        "  - Child age < 8 yrs: TMP-SMX 10 mg/kg/day TMP (max. 320 mg/day), 50 mg/kg/day SMX (max. 1.6 mg/day) in 2 divided doses x 12 weeks or more + Rifampin 15-20 mg/kg/day (max. 900 mg/day) po once daily x 12 or more weeks + Gentamicin 5 mg/kg IV/IM once daily for the first 7-14 days",
        "Post-exposure prophylaxis after laboratory exposure. Limited data and regimens often not well-tolerated:",
        "  - Doxycycline 100 mg po bid + Rifampin 600 mg po once daily x 3 weeks",
        "  - If B. abortus strain RB51 (resistant to Rifampin): Doxycycline alone x 3 weeks.",
        "  - If Doxycycline not well-tolerated or in pregnancy, TMP-SMX-DS po bid with or without Rifampin 600 mg po once daily x 3 weeks."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "For non-localizing disease and need to avoid Gentamicin, can try Ciprofloxacin 500 mg po bid + (Doxycycline or Rifampin) x 6 weeks."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Treat osteomyelitis or spondylitis for 3 months."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Observational study reports higher frequency (p 0.026) of clearance of Brucella DNA from whole blood with triple therapy: (Gentamicin or Streptomycin) + Doxycycline + Rifampin: Antimicrob Agents Chemother 58:7541, 2014 ;PLos neglected Tropical Diseases. 2023; 17: el0011590",
        "Brucellosis reviews: N Engl J Med 352:2325, 2005, PLoS One 7:e32090, 2012, Clin Infect Dis 56:1407, 2013.",
        "Refs for arthritis: MMWR 61:461, 2012;; PLoS One 7:e32090, 2012.",
        "Antibody testing of exposed personnel via State labs or CDC at 2, 4, 6 and 24 weeks; NOTE: poor antibody response to B. abortus strain RB51."
      ]
    }
  ]
}